IFNG and lung cancer: Considering this, Pan et al. designed to use the RAS vaccine in combination with avasimibe, which significantly increased the abundance of CD8+ T cell infiltration and the levels of IFN-γ and granzyme B in lung cancer mouse models, playing a synergistic role [115].